Skip to main navigation

About Us
Programs
Join Us
Investors
Contact Us

Press Releases

Investors & Media

Overview
Press Releases
Events & Presentations
Financials
Stock Information
Analyst Coverage
Governance
Contact & FAQs

Stockholder Tools

Print Page
RSS Feeds
Email Alerts
Contact Us

Year

August 16, 2021

Aerovate Therapeutics Announces Second Quarter 2021 Financial Results

July 19, 2021

Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors

July 2, 2021

Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

June 29, 2021

Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering

May 18, 2021

Aerovate Therapeutics Appoints Timothy Noyes as Chief Executive Officer

August 6, 2020

Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Displaying 31 - 36 of 36

Investors & Media

Overview
Press Releases
Events & Presentations
Financials
Stock Information
Analyst Coverage
Governance
Contact & FAQs

Stockholder Tools

Print Page
RSS Feeds
Email Alerts
Contact Us

About Us
Programs
Join Us
Investors
Contact Us

© 2024 Aerovate Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use